Helsinki, Finland

Karl B Lemström

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Karl B Lemström

Introduction

Karl B Lemström is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of medical science, particularly in the area of organ transplantation and related therapies. With a total of two patents to his name, Lemström's work focuses on improving outcomes for organ transplant recipients.

Latest Patents

Lemström's latest patents include innovations related to growth factor antagonists for organ transplant alloimmunity and arteriosclerosis. These inventions provide materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet-derived growth factor receptors, and other receptors. The goal of these innovations is to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.

Career Highlights

Throughout his career, Lemström has been associated with Vegenics Pty Limited, where he has been able to apply his expertise in developing groundbreaking medical solutions. His work has been instrumental in advancing the understanding and treatment of complications associated with organ transplants.

Collaborations

Lemström has collaborated with esteemed colleagues such as Kari Alitalo and Antti I Nykänen. These partnerships have further enriched his research and contributed to the success of his innovations.

Conclusion

Karl B Lemström's contributions to the field of organ transplantation through his innovative patents highlight his dedication to improving medical outcomes. His work continues to influence the landscape of transplant medicine and offers hope for better patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…